3rd Quarter - Report — GILEAD SCIENCES, INC. for GILEAD SCIENCES INC (2008)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

GILEAD SCIENCES, INC.

Client

GILEAD SCIENCES INC

Income

—

Expenses

$230,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
3rd Quarter - Report (this page)	Oct 20, 2008	$230,000	Replaced
3rd Quarter - Amendment	Oct 28, 2008	$240,000	Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

International Trade Issues Global Health Issues Domestic HIV Policy Issues H.R.5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV AIDS H.R. 1943 - Stop AIDS in Prison Act H.R. 822 - Routine HIV/AIDS Screening Coverage Act S. 2162 - Veterans' Mental Health and other Care Improvements Act H.R. 6114 - Simplifying and Updating National Standards to Encourage Testing of the Human Immunodeficiency Virus Act

Lobbyist	Covered position, as disclosed
CRISTIN LIS	—

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); SENATE

Bills named: H.R. 6114 (110th), H.R. 822 (110th), H.R. 1943 (110th), S. 2731 (110th), H.R. 5501 (110th), S. 2162 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.